Recently, the serum concentration of tau protein and S100B have been reported to be increased in neonatal HIE (or bilirubin encephalopathy), and are suggested as biomarkers of neonatal brain damage [17–19]. The gene discussed is MAPT; the disease is perinatal asphyxia.